	Model-informed dose optimization of carvedilol and nebivolol in cirrhotic patients: a pilot randomized clinical study. Sci Rep Tarek M, Ali AA, Biomy R, Abdelkawy K, El-Khateeb E. PMID: 42297946 [PubMed - indexed for MEDLINE]
	Stem cell therapies for liver cirrhosis: a GRADE evaluation through a systematic review. Ann Hepatol Prasad M, Shenoy P, Prabhakar T, Gupta S, Gupta S, Gautam S, Ghai VK, L SA, Keerthi K, Vats S, Ahmed F, Rewari BB. PMID: 42297141 [PubMed - as supplied by publisher]
	One-stage hepatectomy may be a safe and feasible alternative to ALPPS for hepatocellular carcinoma with liver fibrosis or cirrhosis and FLR/SLV ratio of 30% - 40% - A multicenter study. Eur J Surg Oncol Yang H, Gao J, Mo S, Zhan G, Huang J, Lu Z, Gong W, Peng T, Xiang B. PMID: 42296572 [PubMed - as supplied by publisher]
	Clinical and Laboratory Indicators Associated with Cirrhosis Severity. Clin Lab Chen J, Lei JB, Li JX, Chen GY, Song YH, Feng JA. PMID: 42295290 [PubMed - indexed for MEDLINE]
	Prevalence of Steatotic Liver Disease with Fibrosis and Diagnostic Screening Tools in Patients with Psoriasis. Acta Derm Venereol Näslund-Koch C, Løvendorf MB, Martin HM, Johansen MB, Trelle MB, Zachariae C, Gluud LL, Skov L. PMID: 42294564 [PubMed - indexed for MEDLINE]
	Quality of Evidence in Remote Monitoring of Patients With Liver Cirrhosis: A Systematic Review. Gastro Hep Adv van Ruijven B, Lantinga MA, Drenth JPH, Pierik MJ, Gevers TJG, Veldhuijzen G. PMID: 42293777 [PubMed]
	Assessment of Esophageal and Gastric Varices in Patients With Cirrhosis for Clinical Trials: A Centralized Blinded Evaluation System. Gastro Hep Adv Alkhouri N, Vuppalanchi R, Noureddin M, Lawitz E, Mena E, Gunn NT, Jamil K, Zuckerman S, Harrison SA, Chalasani N. PMID: 42293772 [PubMed]
	Machine learning-based risk prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a cohort study. Front Med (Lausanne) Song L, Qiao X, Gao L, Sun Y, Feng D, Yang H. PMID: 42292236 [PubMed]
	Association Between Dietary Patterns and Sarcopenia in Patients With Liver Cirrhosis: A Cross-Sectional Study. Health Sci Rep Sobhrakhshankhah E, Hassanzadeh P, Karimi S, Mansoorian MR, Kolahdoozan N, Doustmohammadian A. PMID: 42291714 [PubMed]
	Three-Dimensional Portal Vein Geometry Predicts Post-TIPS -Hepatic Encephalopathy and Variceal Rebleeding: A Multicenter Study. Liver Int Wan S, Li J, Zhang X, Zhang L, Shi F, Yan P, Liu X, Zhang M, Song B. PMID: 42287031 [PubMed - indexed for MEDLINE]
	Changing etiological spectrum of cirrhosis in China: a systematic review and meta-analysis. BMC Gastroenterol He C, Liu P, Liu X, Cai P, Fu X, Li J. PMID: 42286454 [PubMed - as supplied by publisher]
	Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovation. Med Dunn W, Alkhouri N. PMID: 42285042 [PubMed - indexed for MEDLINE]
	Experimental Study of YaJieShaBa Antialcoholic Hepatic Fibrosis Through TGF-Î²1/Smad Signaling Pathway. Mediators Inflamm Zhang L, Bai Y, Luo S, Liu F, Zheng L, Wan Y, Wu X, Chen Q, Xie Y, Guo P. PMID: 42283336 [PubMed - indexed for MEDLINE]
	Evidence-Based Frameworks Increase Engagement in Serious Illness Communication Conversations for Patients With Cirrhosis. Am J Hosp Palliat Care Brown C, Ford T, Hernandez R, Aksan N, Brooke E, Pignone M, Muir AJ, Sudore RL. PMID: 42283195 [PubMed - as supplied by publisher]
	Longitudinal Inpatient Trajectories After Splenic Artery Embolization in Cirrhosis: Real-World Evidence from Kazakhstan. J Clin Med Doszhan A, Malayev N, Baigenzhin A, Tostanovskaya N, Abdikarimov A, Pavlova K, Nauryzbayeva A, Abzhaparova B, Imambaeva G. PMID: 42279197 [PubMed]
	Secondary prophylaxis of SBP in cirrhosis: trimethoprim-sulfamethoxazole vs. ciprofloxacin in a propensity-matched cohort. Ann Hepatol Osman MM, Sims OT, Chiang DJ. PMID: 42276325 [PubMed - as supplied by publisher]
	Bridging Evidence and Practice: The role of implementation science to optimize plasma transfusion in cirrhosis. J Thromb Haemost Afzal A, Stanworth SJ, Crawshaw J. PMID: 42276272 [PubMed - as supplied by publisher]
	Two-step care pathways for advanced MASLD in primary and hospital care: A multicenter study. Hepatol Commun Driessen S, van Son KC, Riemersma TR, Stramigioli E, Haverkamp GLG, Denters MJ, Alblas G, Tjwa ETTL, Hanssen NMJ, Pinto-Sietsma SJ, Vali Y, Hamer HM, van Kleef LA, Leeming DJ, Lønsmann I, Karsdal MA, Castro Cabezas M, Takkenberg RB, Brouwer WP, Schers HJ, Nieuwdorp M, Drenth JPH, Tushuizen ME, Holleboom AOG. PMID: 42275588 [PubMed - indexed for MEDLINE]
	Physical frailty is the most important predictor of early mortality in hospitalized patients with decompensated cirrhosis. Hepatol Commun D'Arcangelo F, Vivian LM, Ferrarese A, Gambato M, Germani G, Senzolo M, Russo FP, Burra P, Zanetto A. PMID: 42275585 [PubMed - indexed for MEDLINE]
	Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival. Liver Int Bienvenue I, Roux O, Coilly A, Abergel A, Antonini T, Artzner T, Boillot O, Chermak F, Conti F, Dharancy S, Duvoux C, Elkrief L, Farrugia M, Francoz C, Giguet B, Hardwigsen J, Houssel-Debry P, Hilleret MN, Kamar N, Latournerie M, Meszaros M, Radenne S, Roche B, Salamé E, Verhoeven-Weil D, Samuel D, Zoulim F, Dumortier J, Villeret F. PMID: 42274284 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 38676

Page 1 of 1934



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy